These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19064138)

  • 1. Black box warnings-implications in practice.
    Zarowitz BJ
    Geriatr Nurs; 2008; 29(6):402-9. PubMed ID: 19064138
    [No Abstract]   [Full Text] [Related]  

  • 2. Primum non nocere and "black box" warnings.
    Pearlman DS
    J Allergy Clin Immunol; 2006 Jan; 117(1):30-1. PubMed ID: 16387580
    [No Abstract]   [Full Text] [Related]  

  • 3. Black box warnings: what do they mean to pharmacists and patients.
    Martin CM; Borgelt L
    Consult Pharm; 2012 Jul; 27(7):482-92. PubMed ID: 22910129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Black box" 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk.
    Murphy S; Roberts R
    J Allergy Clin Immunol; 2006 Jan; 117(1):34-9. PubMed ID: 16387581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Black box" warning: wake-up call or overreaction?
    Szefler SJ; Whelan GJ; Leung DY
    J Allergy Clin Immunol; 2006 Jan; 117(1):26-9. PubMed ID: 16387579
    [No Abstract]   [Full Text] [Related]  

  • 6. Black box warnings in prescription drug labeling: results of a survey of 206 drugs.
    Beach JE; Faich GA; Bormel FG; Sasinowski FJ
    Food Drug Law J; 1998; 53(3):403-11. PubMed ID: 10346718
    [No Abstract]   [Full Text] [Related]  

  • 7. Black box warning contraindicated comedications: concordance among three major drug interaction screening programs.
    Wang LM; Wong M; Lightwood JM; Cheng CM
    Ann Pharmacother; 2010 Jan; 44(1):28-34. PubMed ID: 20040698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
    Poser S
    Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
    [No Abstract]   [Full Text] [Related]  

  • 9. Updated clinical practice guidelines on erythropoiesis-stimulating agents.
    Silver SM
    Clin Adv Hematol Oncol; 2007 Dec; 5(12):945-6. PubMed ID: 18277954
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA cracks down on labeling, initiates trial result reporting.
    Osborne R; Waltz E
    Nat Biotechnol; 2008 Nov; 26(11):1203-4. PubMed ID: 18997742
    [No Abstract]   [Full Text] [Related]  

  • 11. Thinking outside the (black) box: a new research agenda.
    Seligman PJ
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):387-9. PubMed ID: 16739245
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety-related drug labeling changes approved by FDA.
    White GG
    J Toxicol Clin Toxicol; 1998; 36(3):265-7. PubMed ID: 9678979
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA boxed warnings: how to prescribe drugs safely.
    O'Connor NR
    Am Fam Physician; 2010 Feb; 81(3):298-303. PubMed ID: 20112888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avoiding drug interactions.
    Generali J
    Am Fam Physician; 2000 Mar; 61(6):1628, 1630, 1637. PubMed ID: 10750872
    [No Abstract]   [Full Text] [Related]  

  • 15. Bringing greater transparency to "black box" warnings.
    Buckley NA; Rossi S
    Clin Toxicol (Phila); 2011 Jul; 49(6):448-51. PubMed ID: 21824055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A needed technical fix?
    Robertson WO
    Vet Hum Toxicol; 2000 Apr; 42(2):118-9. PubMed ID: 10750184
    [No Abstract]   [Full Text] [Related]  

  • 17. Institute of Medicine's new drug safety report: implications for Canada.
    Cassels A
    CMAJ; 2006 Dec; 175(12):1515-6. PubMed ID: 17146086
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 19. New pediatric dosage rules: information and testing.
    Feeg VD
    Pediatr Nurs; 1998; 24(6):518, 613. PubMed ID: 10085992
    [No Abstract]   [Full Text] [Related]  

  • 20. Proposed NSAID package insert labeling.
    Food and Drug Administration U.S. Public Health Service
    J Pain Palliat Care Pharmacother; 2006; 20(1):49-55. PubMed ID: 16687359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.